Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis

American Journal of Surgery
K TakedaY Kakugawa

Abstract

This study was conducted to determine whether continuous regional arterial infusion (CRAI) of the protease inhibitor, nafamostat mesylate, in acute necrotizing pancreatitis, would reduce mortality. In addition, the effectiveness of CRAI of the antibiotic imipenem in combination with nafamostat was investigated for its effect in preventing secondary infection of the pancreatic necrotic tissue. Fifty- three patients with acute necrotizing pancreatitis were divided into three groups: Group I, 16 patients who were referred >8 days after disease onset, received intravenous nafamostat and antibiotics; Group II, 22 patients referred within 7 days, received nafamostat via CRAI, and antibiotics intravenously; Group III, 15 patients referred within 7 days, received both nafamostat and imipenem via CRAI. The mortality rates in Group II (13.6%) and group III (6.7%) were significantly reduced, as compared with that in group I (43.8%). The incidence of infection of pancreatic necrosis in group III (0%) was significantly lower than those in group I (50%) and in group II (22.8%). CRAI of nafamostat and imipenem in acute necrotizing pancreatitis was effective in reducing mortality and preventing the development of pancreatic infection.

References

May 1, 1978·The British Journal of Surgery·C W ImrieL H Blumgart
Mar 1, 1991·Drugs·C Wilson, C W Imrie
Mar 1, 1974·The British Journal of Surgery·J E TrapnellE H Duncan
Jun 1, 1969·The American Journal of Digestive Diseases·F W NugentS Zuberi

❮ Previous
Next ❯

Citations

Jan 9, 2008·Abdominal Imaging·Yusuke SakuharaHiroki Shirato
Oct 29, 2008·Cardiovascular and Interventional Radiology·Motoo NakagawaYuta Shibamoto
Feb 8, 2006·Journal of Hepato-biliary-pancreatic Surgery·Kazunori TakedaUNKNOWN JPN
Jul 13, 2004·Current Gastroenterology Reports·Girish Mishra, Benoit C Pineau
Sep 28, 2007·Current Treatment Options in Gastroenterology·Mehran Fotoohi, L William Traverso
Dec 4, 2002·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·Tomoki FuruyaShigeki Matsuo
May 5, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·Y AsanumaK Koyama
Jul 14, 1999·Gut·S W SchmidM W Büchler
Apr 21, 2012·International Journal of Inflammation·Yoshihisa TsujiChiba Tsutomu
Jul 18, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·C Bassi
Jul 18, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·T Keck
Jul 18, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·K TakedaS Matsuno
Aug 2, 2003·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Masahiko HirotaMichio Ogawa
Jan 7, 2014·Internal Medicine·Kazuyuki MatsumotoKazuhide Yamamoto
May 22, 2008·World Journal of Gastroenterology : WJG·Ulrich-Christian BangFlemming Bendtsen
Nov 15, 2008·World Journal of Gastroenterology : WJG·Yoshifumi InoTetsuhide Ito
Mar 25, 2009·Journal of Gastroenterology·Takashi UedaHarumasa Ohyanagi
Jan 6, 2016·The Indian Journal of Surgery·Rahman ŞenocakOrhan Kozak
Apr 13, 2010·Burns : Journal of the International Society for Burn Injuries·Atsumori HamahataDaniel L Traber
Dec 10, 1999·Journal of Vascular and Interventional Radiology : JVIR·H AnaiS Miyamoto
Oct 24, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Yoshihisa TsujiTsutomu Chiba
Aug 4, 2005·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Takao SaotomeYoshihide Fujiyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.